Prevention of no-reflow/slow-flow phenomenon during rotational atherectomy—A prospective randomized study comparing intracoronary continuous infusion of verapamil and nicorandil

2007/09/17 by Hitoshi Matsuo, Sachiro Watanabe, Takatomo Watanabe +9 · 20 citations
Medicine · #Coronary Interventions and Diagnostics #Acute Myocardial Infarction Research #Antiplatelet Therapy and Cardiovascular Diseases

paper · doi:10.1016/j.ahj.2007.07.036

Cited by

• Comparison of Frequency of Complications With On-Label Versus Off-Label Use of Rotational Atherectomy
• Adenosine and verapamil for no-reflow during primary percutaneous coronary intervention in people with acute myocardial infarction. [europepmc]
• Protective effect of nicorandil on myocardial injury following percutaneous coronary intervention in older patients with stable coronary artery disease: Secondary analysis of a randomized, controlled trial (RINC). [europepmc]
• A New Era for Rotational Atherectomy: An Australian Perspective. [europepmc]
• Halfway rotational atherectomy for calcified lesions: Comparison with conventional rotational atherectomy in a propensity-score matched analysis. [europepmc]
• Comparison of complications with a 1.25-mm versus a 1.5-mm burr for severely calcified lesions that could not be crossed by an intravascular ultrasound catheter. [europepmc]
• Rotational Atherectomy: A Contemporary Appraisal. [europepmc]
• Comparison of the incidence of slow flow after rotational atherectomy with IVUS-crossable versus IVUS-uncrossable calcified lesions. [europepmc]
• Safety and effectiveness of coronary intravascular lithotripsy in eccentric calcified coronary lesions: a patient-level pooled analysis from the Disrupt CAD I and CAD II Studies. [europepmc]
• In-Hospital Peak Glycemia in Predicting No-Reflow Phenomenon in Diabetic Patients with STEMI Treated with Primary Percutaneous Coronary Intervention. [europepmc]
• Modifiable and unmodifiable factors associated with slow flow following rotational atherectomy. [europepmc]
• Long-term outcome of rotational atherectomy according to burr-to-artery ratio and changes in coronary artery blood flow: Observational analysis. [europepmc]
• The effectiveness of alprostadil in treating coronary microcirculation dysfunction following ST-segment elevation myocardial infarction in a pig model. [europepmc]
• Clinical expert consensus document on rotational atherectomy from the Japanese association of cardiovascular intervention and therapeutics: update 2023. [europepmc]
• Prediction of the debulking effect of rotational atherectomy using optical frequency domain imaging: a prospective study. [europepmc]
• Study design and rationale for comparison of the incidence of slow flow following rotational atherectomy to severely calcified coronary artery lesions between short single session and long single session: The randomized ROTASOLO trial. [europepmc]
• Rotational Atherectomy, Orbital Atherectomy, and Intravascular Lithotripsy Comparison for Calcified Coronary Lesions. [europepmc]
• Breaking the Barrier: Unraveling the No-Reflow Phenomenon in Cardiovascular Medicine. [europepmc]
• Comparison of the incidence of slow flow following rotational atherectomy to severely calcified coronary artery lesions between short single session and long single session strategies: the randomized ROTASOLO trial. [europepmc]
• Clinical expert consensus document on rotational atherectomy from the Japanese association of cardiovascular intervention and therapeutics: update 2026. [europepmc]